Who Buys Clindamycin from India — 1029 Importers Behind a $90.2M Market
India's clindamycin import market is served by 1029 active buyers who collectively imported $90.2M across 7,242 shipments. CARDINAL HEALTH (UNITED STATES) leads with a 6.4% market share, followed by EVERSANA LIFE SCIENCE SERVICES, LLC and IPD, SC, USA. The top 5 buyers together control 26.8% of total import value, reflecting a moderately competitive buyer landscape.
Top Clindamycin Importers — Ranked by Import Value
CARDINAL HEALTH (UNITED STATES) is the leading clindamycin importer from India, holding a 6.4% share of the $90.2M market across 7,242 shipments from 1029 buyers. The top 5 buyers — CARDINAL HEALTH (UNITED STATES), EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES), IPD, SC, USA (UNITED STATES), AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), AUROLOGISTICS LLC AUROBINDO PHARM (UNITED STATES) — collectively control 26.8% of total import value.
Top Clindamycin Buyers & Importers
Ranked by import value · 1029 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | CARDINAL HEALTHUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $5.8M | 5 | 6.4% |
| 2 | EVERSANA LIFE SCIENCE SERVICES, LLCUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $4.8M | 5 | 5.3% |
| 3 | IPD, SC, USAUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $4.8M | 5 | 5.3% |
| 4 | AUROLOGISTICS LLC (AUROBINDO PHARMAUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $4.7M | 5 | 5.2% |
| 5 | AUROLOGISTICS LLC AUROBINDO PHARMUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $4.1M | 5 | 4.5% |
| 6 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $3.8M | 5 | 4.2% |
| 7 | AIM RX 3PL, LLCUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $3.3M | 5 | 3.6% |
| 8 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $3.1M | 5 | 3.4% |
| 9 | LEGEND CREATIVES CO. LTD.MYANMAR CLINDAMYCIN PHOSPHATE GEL USP 1% W/W (CLINDAMYCIN PHOSPHATE GEL USP ? 1% W/WCLINDAMYCIN PHOSPHATE GEL USP ? 1% W/W ( | $3.0M | 5 | 3.3% |
| 10 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $2.9M | 5 | 3.3% |
| 11 | AUROLOGISTICS LLCUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $2.8M | 5 | 3.2% |
| 12 | SYNERMED PHARMACEUTICALS (KENYA)LTDKENYA BERGCLIN 300 (CLINDAMYCIN CAPSULES BP 30CLINDAMYCIN 300 MG TABLET B.NO.KE 14 202CLINDAMYCIN 300 MG TABLET B.NO.KE 14 201 | $2.7M | 5 | 2.9% |
| 13 | NELPA LIFESCIENCES INCPHILIPPINES PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, CLINDASAPH-150PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, CLINDASAPH-300PHARMACEUTICAL PRODUCTS- CLINDASAPH-600 | $2.1M | 5 | 2.3% |
| 14 | EVERSANA LIFE SCIENCE SERVICES LLCUNITED STATES CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $1.8M | 5 | 2.0% |
| 15 | UNIQUE PHARMA,CONGO DR | $1.8M | 5 | 1.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Clindamycin — and from which countries?
Flow of Clindamycin exports from India: each country's share and the named importers behind the numbers
Clindamycin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $55.0M through 688 shipments. This represents a market share of 60.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• CARDINAL HEALTH - $5.8M (10.5% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES, LLC - $4.8M (8.7% of country's total business)
• IPD, SC, USA - $4.8M (8.7% of country's total business)
• AUROLOGISTICS LLC (AUROBINDO PHARMA - $4.7M (8.6% of country's total business)
• AUROLOGISTICS LLC AUROBINDO PHARM - $4.1M (7.5% of country's total business)
• Rest of United States's importers - $30.8M (56.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $79.9K, indicating premium pricing strategy compared to the market average of $12.5K.
United States is a key market for Clindamycin imports, representing 60.9% of total trade value.
2Kenya
Kenya emerges as the second largest importing country, achieving a total trade value of $4.6M through 19 shipments. This represents a market share of 5.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Kenya has a diverse importer base, with their top importers including:
• SYNERMED PHARMACEUTICALS (KENYA)LTD - $2.7M (58.1% of country's total business)
• WESSEX PHARMACEUTICALS LIMITED, - $1.2M (27.3% of country's total business)
Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $240.5K, indicating premium pricing strategy compared to the market average of $12.5K.
Kenya is a key market for Clindamycin imports, representing 5.1% of total trade value.
3Philippines
Philippines emerges as the third largest importing country, achieving a total trade value of $3.7M through 4 shipments. This represents a market share of 4.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• NELPA LIFESCIENCES INC - $2.1M (58.0% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $912.8K, indicating premium pricing strategy compared to the market average of $12.5K.
Philippines is a key market for Clindamycin imports, representing 4.0% of total trade value.
4Myanmar
Myanmar emerges as the fourth largest importing country, achieving a total trade value of $3.1M through 3 shipments. This represents a market share of 3.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Myanmar has a diverse importer base, with their top importers including:
• LEGEND CREATIVES CO. LTD. - $3.0M (97.2% of country's total business)
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $1.0M, indicating premium pricing strategy compared to the market average of $12.5K.
Myanmar is a key market for Clindamycin imports, representing 3.4% of total trade value.
5Canada
Canada emerges as the fifth largest importing country, achieving a total trade value of $2.1M through 0 shipments. This represents a market share of 2.3% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $2.1M, indicating premium pricing strategy compared to the market average of $12.5K.
Canada is a key market for Clindamycin imports, representing 2.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Clindamycin buyer market intelligence
1Buyer Segment Analysis
The importation of Clindamycin from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like Cardinal Health and Eversana Life Science Services, LLC in the United States fall into this category. They procure large volumes to supply hospitals, pharmacies, and healthcare providers, often engaging in long-term contracts to ensure consistent supply chains.
- Contract Manufacturers: Aurobindo Pharma, operating through AuroLogistics LLC, exemplifies this segment. They import Clindamycin as an active pharmaceutical ingredient (API) for formulation into finished products, focusing on cost-effective sourcing and maintaining quality standards.
- Re-exporters: Companies like Legend Creatives Co. Ltd. in Myanmar may act as intermediaries, importing Clindamycin for distribution to neighboring regions, leveraging strategic geographic positions to serve broader markets.
Each segment's purchasing patterns are influenced by their operational focus, regulatory compliance requirements, and market demand dynamics.
Country-Specific Import Regulations
TransData Nexus Clindamycin buyer market intelligence
1Country-Specific Import Regulations
United States
1. Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process: Importers must file an entry notice and bond with U.S. Customs. The FDA reviews the entry, and if necessary, inspects the shipment. Products must comply with the Federal Food, Drug, and Cosmetic Act.
3. Estimated Timeline: The review process varies; if no inspection is required, clearance can be swift. If inspection is needed, it may extend the timeline.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30042095 are generally duty-free in the U.S.
Kenya
1. Regulatory Authority: Pharmacy and Poisons Board (PPB).
2. Import Registration Process: Importers must obtain a marketing authorization from the PPB, which includes dossier submission, product evaluation, and approval.
3. Estimated Timeline: The registration process can take several months, depending on the completeness of the application and the PPB's review schedule.
4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 0% import duty in Kenya.
Philippines
1. Regulatory Authority: Food and Drug Administration Philippines.
2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving submission of technical documents, product samples, and payment of fees.
3. Estimated Timeline: The process may take 6 months to a year, depending on the product's risk classification and the FDA's workload.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30042095 are generally exempt from import duties.
Myanmar
1. Regulatory Authority: Food and Drug Administration Myanmar.
2. Import Registration Process: Importers must obtain a Drug Importation Certificate, requiring submission of product dossiers, samples, and compliance with local regulations.
3. Estimated Timeline: The registration process can take several months, subject to the FDA's review procedures.
4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 0% import duty in Myanmar.
Canada
1. Regulatory Authority: Health Canada.
2. Import Registration Process: Requires a Drug Identification Number (DIN) and compliance with the Food and Drugs Act and Regulations.
3. Estimated Timeline: The process can take 6 months to over a year, depending on the product and completeness of the application.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30042095 are generally duty-free in Canada.
Demand Drivers & Market Opportunity
TransData Nexus Clindamycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Clindamycin in importing countries is driven by several factors:
- Disease Prevalence: Clindamycin is essential for treating bacterial infections, including skin infections, respiratory tract infections, and certain types of pneumonia. High prevalence of these conditions increases demand.
- Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the WHO's Essential Medicines List includes Clindamycin, guiding national procurement strategies.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased procurement of essential antibiotics like Clindamycin to meet public health needs.
- Tender-Based Purchasing: Public sector procurement often involves competitive tendering, ensuring cost-effective acquisition of medicines.
With 1,029 buyers across 144 countries, the global market for Clindamycin reflects its critical role in healthcare systems worldwide.
Common Questions — Clindamycin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest clindamycin buyer importing from India?
Based on import volume and value, CARDINAL HEALTH (UNITED STATES) leads with $5.8M in imports and a 6.4% market share — the highest of any single clindamycin importer. EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES) and IPD, SC, USA (UNITED STATES) are the next largest buyers.
QHow many companies buy clindamycin from India?
There are 1029 active clindamycin buyers importing from India, with a combined market of $90.2M across 7,242 shipments to 144 countries. The top 5 buyers hold 26.8% of total import value, while the remaining 1024 buyers handle the other 73.2%.
QWhich countries import the most clindamycin from India?
The top importing countries for clindamycin from India are United States (60.9%), Kenya (5.1%), Philippines (4.0%), Myanmar (3.4%), Canada (2.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of clindamycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for clindamycin from India?
The average import transaction value for clindamycin from India is $12.5K, with an average unit price of $4.78 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Clindamycin buyer market intelligence
1Buyer Segment Analysis
The importation of Clindamycin from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like Cardinal Health and Eversana Life Science Services, LLC in the United States fall into this category. They procure large volumes to supply hospitals, pharmacies, and healthcare providers, often engaging in long-term contracts to ensure consistent supply chains.
- Contract Manufacturers: Aurobindo Pharma, operating through AuroLogistics LLC, exemplifies this segment. They import Clindamycin as an active pharmaceutical ingredient (API) for formulation into finished products, focusing on cost-effective sourcing and maintaining quality standards.
- Re-exporters: Companies like Legend Creatives Co. Ltd. in Myanmar may act as intermediaries, importing Clindamycin for distribution to neighboring regions, leveraging strategic geographic positions to serve broader markets.
Each segment's purchasing patterns are influenced by their operational focus, regulatory compliance requirements, and market demand dynamics.
Country-Specific Import Regulations
TransData Nexus Clindamycin buyer market intelligence
1Country-Specific Import Regulations
United States
1. Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process: Importers must file an entry notice and bond with U.S. Customs. The FDA reviews the entry, and if necessary, inspects the shipment. Products must comply with the Federal Food, Drug, and Cosmetic Act.
3. Estimated Timeline: The review process varies; if no inspection is required, clearance can be swift. If inspection is needed, it may extend the timeline.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30042095 are generally duty-free in the U.S.
Kenya
1. Regulatory Authority: Pharmacy and Poisons Board (PPB).
2. Import Registration Process: Importers must obtain a marketing authorization from the PPB, which includes dossier submission, product evaluation, and approval.
3. Estimated Timeline: The registration process can take several months, depending on the completeness of the application and the PPB's review schedule.
4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 0% import duty in Kenya.
Philippines
1. Regulatory Authority: Food and Drug Administration Philippines.
2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving submission of technical documents, product samples, and payment of fees.
3. Estimated Timeline: The process may take 6 months to a year, depending on the product's risk classification and the FDA's workload.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30042095 are generally exempt from import duties.
Myanmar
1. Regulatory Authority: Food and Drug Administration Myanmar.
2. Import Registration Process: Importers must obtain a Drug Importation Certificate, requiring submission of product dossiers, samples, and compliance with local regulations.
3. Estimated Timeline: The registration process can take several months, subject to the FDA's review procedures.
4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 0% import duty in Myanmar.
Canada
1. Regulatory Authority: Health Canada.
2. Import Registration Process: Requires a Drug Identification Number (DIN) and compliance with the Food and Drugs Act and Regulations.
3. Estimated Timeline: The process can take 6 months to over a year, depending on the product and completeness of the application.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30042095 are generally duty-free in Canada.
Demand Drivers & Market Opportunity
TransData Nexus Clindamycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Clindamycin in importing countries is driven by several factors:
- Disease Prevalence: Clindamycin is essential for treating bacterial infections, including skin infections, respiratory tract infections, and certain types of pneumonia. High prevalence of these conditions increases demand.
- Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the WHO's Essential Medicines List includes Clindamycin, guiding national procurement strategies.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased procurement of essential antibiotics like Clindamycin to meet public health needs.
- Tender-Based Purchasing: Public sector procurement often involves competitive tendering, ensuring cost-effective acquisition of medicines.
With 1,029 buyers across 144 countries, the global market for Clindamycin reflects its critical role in healthcare systems worldwide.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1029 global importers of Clindamycin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 7,242 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 144 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7,242 Verified Shipments
1029 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists